US$ 20.14
glp-1 companies Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating The New York Times spotlighted
Description
doi: 10.2337/dci24-0003

Deliberate protein targeting of 0.7-1.0 grams per pound of goal body weight helps preserve lean mass during rapid weight loss

The first clinical trial of exenatide in Parkinsons was a Phase IIa trial to determine if the drug was safe to use in people with Parkinsons

It's also the perfect time to track your cravings and feelings of fullness , so you can see your progress and adjust your eating habits mindfully
